Navigation Links
Aiming at Multiple Alzheimer's Proteins May be Key to Success
Date:10/21/2008

r's-related proteins before they begin to misfold and start their toxic buildup. "Right now, we're treating the symptoms of the disease -- only slowing cognitive decline and memory loss in patients," says Dr. Weaver. "My colleagues and I are using this grant to design drugs that may one day prevent or even reverse progression of Alzheimer's disease."

The design strategy begins at Dalhousie University where researchers are creating new, unique drug compounds and testing each drug's ability to bind to both proteins and prevent shape changes. To date, Dr. Weaver's laboratory has produced more than 240 variations of the most effective compound. Once identified, these synthesized compounds are sent for further analysis to Edwin De Pauw, Ph.D. and his group at the University of Liege in Belgium. Promising compounds that pass this second step in testing then move on to preliminary safety and efficacy investigations using animal models in the laboratory of Ottavio Arancio, M.D., Ph.D. at Columbia University Medical Center in New York.

Since accepting the award from AHAF last year, this international team has made impressive progress. These easily reproducible chemical compounds have shown a remarkable ability to prevent misfolding of both proteins in the Dalhousie laboratory. This activity has been confirmed at the University of Liege, and exciting results are reported at Columbia. "Our lead compound is very effective in mice with conditions similar to Alzheimer's. It can be delivered orally, inhibits aggregation of these proteins, protects brain cells from beta amyloid damage, restores normal memory functioning and shows no toxicity at high doses," says Dr. Weaver. According to AHAF's Director of Research Grants, Guy Eakin, Ph.D., "This work is particularly important because Alzheimer's disease patients are often taking several medications for other health conditions. Rather than give them a 'cocktail' of drugs that might produce harmful interactions, Dr. Wea
'/>"/>

SOURCE American Health Assistance Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... Spanje, July 4, 2015 ... aan eerstelijns chemotherapie voor patiënten met niet-resectabele ... verlengt de progressievrije overleving in dat orgaan. ... colorectale kanker (mCRC) die alleen binnen de ... in progressievrije overleving (PFS) in de lever ...
(Date:7/3/2015)... , July 3, 2015 ... "Cardiac Monitoring & Cardiac Rhythm Management Market ECG, ... Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, ... by MarketsandMarkets, the global Cardiac Monitoring (CM) and ... to reach $26,646.5 Million by 2020 from $21,137.7 ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the ... an online service for the management of data on ... today that PharmaShine now includes the 2014 Open Payments ... Medicare Services on June 30. The data disclosed on ... transactions between industry and providers totaling $6.49 billion and ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... 2012  Atlanta-based Acella Pharmaceuticals, LLC, announces the addition ... and Marketing of their commercial team. Tom will ... Acella,s product line.    Tom is ... bringing more than 11 years of industry experience, ...
... 2012   Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... 31, 2012 before market open on Tuesday May 8, 2012. ... webcast at 9:00 am Eastern Time (6:00 am Pacific Time) ... Domestic callers: 1 (866) 543-6411 International callers: +1 (617) 213-8900 ...
Cached Medicine Technology:
(Date:7/5/2015)... ... 2015 , ... Women’s Excellence in Wellness, powered by Movestrong is ... special consists of 2 months of unlimited classes for just $65. Student ID is ... 1410 South Lapeer Road in Lake Orion. , Women’s Excellence is ...
(Date:7/4/2015)... , ... July 04, 2015 , ... ... Surgeons published the results of an annual member survey , detailing the ... States. More recently, the group broke that raw data down into charts detailing ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler ... recognition of technical sales expertise from the North American Board of Certified Energy ... is the most highly respected and well established national certification organization for renewable ...
(Date:7/3/2015)... ... ... On June 30th SEO authority and veteran Internet marketing ... "Page One Engine" . The program, which has been hailed as the new ... marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an in-depth review of ...
(Date:7/3/2015)... ... 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Rhinoplasty Symposium . To be held from March 4th - 6th, the 2016 (a ... Westin Galleria Dallas. , Designed to take participants from the basic training and fundamentals ...
Breaking Medicine News(10 mins):Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3
... With sights set on advanced science degrees and careers ... now have the highest honor they can garner for ... Eastham, a junior chemistry major, and Thomas Markovich, a ... Barry M. Goldwater Scholars for the 2011-2012 academic year. ...
... 6, 2011 Researchers at The Scripps Research Institute have found ... to pour in and activate an immune response. This process can ... it fallssuch as when immune cells are "called" from the body,s ... The study, recently published online ahead of print by Nature ...
... international panel of experts from The Heart Rhythm Society ... recommendations for all health care professionals about cardiovascular genetic ... Sessions. Silvia G. Priori, MD, PhD, a ... director of the Cardiovascular Genetics Program at NYU Langone ...
... National Academies Keck Futures Initiative announced today the recipients ... to support interdisciplinary research on imaging science. The ... such research, which was the subject of the eighth ... "We received far more high-quality proposals than funds available," ...
... A study published in the June 2011 issue of ... the association between patientphysician gender concordance and weight-related counseling ... and Johns Hopkins University found that obese male patients ... counseling than obese women seeing a female physician. ...
... Reporter , THURSDAY, May 5 (HealthDay News) -- You stand ... while you,re in an exercise facility than if you,re in ... Overall, 50 percent of cardiac arrest victims survived ... sort of exercise was happening, whereas only 36 percent of ...
Cached Medicine News:Health News:2 students named Goldwater Scholars, 2 receive honorable mention 2Health News:2 students named Goldwater Scholars, 2 receive honorable mention 3Health News:Scripps Research scientists show how shifts in temperature prime immune response 2Health News:Scripps Research scientists show how shifts in temperature prime immune response 3Health News:New guidelines for cardiovascular genetic testing 2Health News:Keck Futures Initiative awards $1 million for 13 research projects 2Health News:Keck Futures Initiative awards $1 million for 13 research projects 3Health News:Keck Futures Initiative awards $1 million for 13 research projects 4Health News:Keck Futures Initiative awards $1 million for 13 research projects 5Health News:Weight-loss counseling most prevalent between male physicians and obese men 2Health News:Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds 2Health News:Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds 3
Microforceps: Claes ILM Forceps...
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps with "nail-like" end-gripping platforms; for precise grasping and improved visualization of thin membranes in the macular region....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products: